Favorite quote:

"As to methods there may be a million and then some, but principles are few. The man who grasps principles can successfully select his own methods. The man who tries methods, ignoring principles, is sure to have trouble."

Ralph Waldo Emerson


Dr. Nguyen Phuoc Long is a young scientific enthusiast with a combined background in clinical medicine, omics sciences, and data science. He graduated from the University of Medicine and Pharmacy at Ho Chi Minh City as an M.D. (2015). He completed his integrative M.Sc.-Ph.D. training at the College of Pharmacy, Seoul National University (2016 - 2020). Dr. Long was a postdoctoral fellow at the Research Institute of Pharmaceutical Sciences, Seoul National University. He has joined the Department of Pharmacology, Inje University recently as a research professor (non-tenure-track) since September 2020. He has been published more than 45 papers, mainly in respectable scientific journals. Besides, Dr. Long holds two patents registered in the Republic of Korea.

He believes that integrative data-driven and knowledge-based implementation will have a significant impact on the progress of medicine. Up to this point, he collaborates closely with his colleagues on utilizing multi-omics platforms, including genomics, transcriptomics, and lipido-metabolomics, to facilitate the advancement of translational research, preventive medicine, and precision medicine. In addition, he has been involved in the establishment of model-informed precision dosing for improving the clinical outcome of patients. He also has a keen interest in finding the mechanisms of human diseases using a combined strategy of molecular biology and bioinformatics. Besides, he has optimized mass spectrometry-based metabolomics and lipidomics methods for translational and clinical research. Improving and standardizing analytical and computational pipelines for lipidomics and metabolomics research is also his interest. Last but not least, environmental pollution and the global burden of diseases have lately become his research routine.

A background comprised of various disciplines has given Dr. Long a unique opportunity to work in various fields. Shortly, he would like to extend his capability to fit the requirements of the sophisticated lipido-metabolomics and multi-omics integration approaches for large-scale omics-based research of chronic and infectious diseases.

What boundaries do you want to break next?


  • Omics sciences

  • Cancer research

  • Biomarker discovery and validation

  • Biostatistics and machine learning

  • Bioinformatics

  • Pharmacology

  • Metabolism

  • Environmental health

  • Neuroscience

  • Mass spectrometry

Full CV of Dr. Long can be found here.

Recent representative works

Advances in LC-MS-based lipidomics

doi: 10.1007/s41664-020-00135-y

Selected to be the cover figure of the special issue: Metabolomics: state of art in method development and applications - Journal of Analysis and Testing [link]

Nanopolystyrene Toxicology - Multi-omics profiling

doi: 10.1016/j.jhazmat.2020.123005

Journal of Hazardous Materials

Adaptive metabolomics in medicine

doi: 10.3390/metabo10020051

Selected to be a feature paper of Volume 10, Issue 2 (February 2020) - Metabolites - Affiliated journal of the Metabolomics Society [link]

Omics-Based biomarkers for pancreatic cancer

doi: 10.3390/cancers11020155

Cancers - Affiliated journal of The Irish Association for Cancer Research

Metabolomics and pancreatic cancer diagnosis

doi: 10.1007/s11306-018-1404-2

Metabolomics - Metabolomics Society

Deep learning and cervical cancer diagnosis

Machine learning, lipidomics, and adulterated admixture detection

doi: 10.1016/j.foodres.2017.08.006

Food Research International - The journal of the Canadian Institute of Food Science and Technology

Very short update of personal activities

Update 1 September 2020

I joined Inje University and work as a research professor (non-tenure-track) in pharmaco-omics.

Update 26 May 2020

Our work entitled "Comprehensive phenotyping and multi-omic profiling in the toxicity assessment of nanopolystyrene with different surface properties" has been published on the Journal of Hazardous Materials. Great!

Update 26 February 2020

Officially awarded the PhD degree. Started working as a BK21 postdoctoral fellow at Research Institute of Pharmaceutical Sciences, Seoul National University.

Update 24 January 2020

I have been leading a fascinating project that aims at finding a multi-omics driven metabolic signature for the early detection of liver cancer since late 2019. Finally we got some results out. Furthermore, hundreds of samples will be analyzed soon to validate our initial results. Fingers crossed!

    • Multi-omics integration is on the way (30 Jan 2020)

Update 18 September 2019

It's efficient to use lme4 and geepack for the longitudinal data modeling. However, please be cautious.

Update 29 April 2019

It's time to try some professional Bayesian data analyses.

    • BEST (t-distribution) is a robust R package for a considerable types of analyses.

    • RJAGS

Update 8 February 2019

I am about to complete my Ph.D. journey. What's more, I'm now a member of a multidisciplinary team of clinical metabolomics!

  • Have passed two defense rounds (latest update on 18 Jun 2019). One more to go (8 July 2019)!

  • I am expected to receive the title of Ph.D. early next year (Feb 2020).

Update 9 January 2019

Started to work on my desired project on pan-cancer and multi-omics with my great collaborators. Good luck to us!

Update 16 December 2018

My first co-author contribution on the field of environmental health is published on Environmental pollution. Congratulations our great team!

Update 5 December 2018

Spend more time to strengthen my mathematical background for statistical learning.

Update 31 August 2018

The first draft of our review regarding a famous family of transcription factors and their roles in cancer is completed. It is going to be submitted soon early September.

    • Accepted and published by International Journal of Molecular Sciences. (Link)

Update 18 August 2018

Have achieved intermediate level of Python for data science and bioinformatics. Still using R as my main environment.

    • Python programmer track completed (36+ hours with 10 courses) (30 September 2018).

    • Python is awesome!

Update 09 July 2018 (started from late 2016):

Being involved in fascinating projects that utilize multi-omics data analysis to get better insights into the pathobiology of various cancers and neurological diseases.

  • A manuscript about X-linked adrenoleukodystrophy is about to be submitted (31 July 2018).

    • Now published on Biochemical and Biophysical Research Communications (Nov 2018).

  • A manuscript about breast cancer had been submitted (20 July 2018).

    • Now published on Frontiers in Oncology (Feb 2019).

Update 02 July 2018:

Small achievement of the year: h-index of 5 (Google Scholar).

  • 27 Nov 2018: h-index of 6 (Google Scholar).

  • 21 Feb 2019: h-index of 7 (Google Scholar).

  • 18 Jun 2019: h-index of 8 (Google Scholar).

  • 30 Jan 2020: h-index of 11 (Google Scholar).

Update 01 June 2018:

I am getting my very first steps on RNA-seq data management, manipulation, and analysis. Exciting! Big thanks to all of the giants of this field!

  • Started to work with multi-omics integration: Unsupervised and supervised methods (13 March 2019).

  • Feel quite comfortable to work with QC and all preparation steps for RNA-seq data as well as DE analysis in R (from the raw count files) (1 March 2019).

  • RNA-Seq Differential Expression Analysis by Datacamp (18 Feb 2019).

  • Single-cell RNA-seq statistical analysis and visualization by Datacamp (13 Sep 2018).

  • Have done a full NGS analysis pipeline for a simple set of samples (25 July 2018).

  • There have been much more to learn. Python for bioinformatics on the way!

Update 23 May 2018:

A mixed background in biomedicine, omics science, data science, and biochemical analysis has given me an unique opportunity to work in various fields of biomedical sciences. In the near future, I would like to extend my capability to fit the requirements of the multi-omics integration approach for precision medicine in oncology and neurology.

Update 07 April 2017:

Welcome to the world, my lovely daughter!